The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Assessing the Cause of Race-Based Differences in Outcomes Observed in the PARADIGM-HF Trial
September 19th 2016Researchers reported black patients enrolled in the PARADIGM-HF study had more favorable prognostic baseline characteristics than white patients in the study. However, black patients exhibited a higher risk for cardiovascular death and hospitalizations.
Omecamtiv Mecarbil Improves Symptoms in Patients with Moderate to Severe Heart Failure
September 19th 2016Study results presented at the 2016 Heart Failure Society of America Scientific Meeting show that treatment with omecantiv mecarbil improved cardiac function and quality of life in patients with heart failure.
Patricia Coyle from Stony Brook Medicine: Teri-PRO Trial shows Continued Benefits of Aubagio
When a medication is approved the data from that time can sometimes be of more value than the trials leading up to the approval. For Aubagio there was a recent study done looking at patient satisfaction and other issues following the approval.
Larry Allen, MD: The Rebirth in Heart Failure
"Heart failure is a disease that happens because of other diseases, so it's kind of the end result of diabetes, heart attacks, and cancer therapies, so it's hard to be a heart failure doctor and not spend a lot of time thinking about all the other medical specialties," concluded Allen.
Larry Allen, MD: Benefits of Shared Decision Making in Heart Failure Patients
With many new drug discoveries and medical devices int he field of advanced heart failure, Larry Allen, MD, MHS and his team are working to create patient decision support tools to help them navigate any challenges.
Talking to Prostitutes: CALPEP's HIV Program
For 30 years, an outreach group in Oakland, CA has been winning the confidence of prostitutes as the first step in helping them be healthy and HIV-free. California Prostitutes Education Project representatives offered tips in a workshop.
Adriana Garriga-Lopez: Celebrating Public Health with a Song, Literally
Bonus video: As the 20th Annual US Conference on AIDS wound down, one presenter stood out—not just for advocacy work. She also sings. Here’s the conclusion of our interview with Adriana Garriga-Lopez, PhD, singing Manuel de Falla's "Nana".
Chase Spurlock from Vanderbilt University: New Blood Test Could Catch Multiple Sclerosis Sooner
At the moment the best way to get a diagnosis of multiple sclerosis is through a brain scan. A team in Tennessee is working to improve that with a blood test that could find the condition sooner allowing for treatment to begin faster.
Aaron Boster: Building Excitement Out of ECTRIMS
As the leading minds in the field of multiple sclerosis came together in London for the annual ECTRIMS conference the end of the conference brought a considerable amount of excitement in everything from the relapsing form to progressive forms.
Aaron Boster from OhioHealth: Extended Data On Lemtrada Shows More Good News
As more and more treatments are approved for patients with multiple sclerosis questions are being answered about their effectiveness long past their approval dates. This is true for many of the medications including lemtrada.
Southern Living: Why the South Is the Epicenter of AIDS in US
Social and religious conservatism appears to have turned the Southern US into the epicenter of the AIDS epidemic in the US, human rights activist Megan McLemore, JD, LLM said at a session on AIDS in the South today at the United States Conference on AIDS. Still another problem is the non-acceptance of LGBT people by many African-American churches, attendees added.
Predicting Worsening RRMS When MRI Doesn't Support It
September 16th 2016“Multiple sclerosis usually begins with a relapsing-remitting (RRMS) phase characterized by clinical relapses and inflammatory demyelination evident on magnetic resonance imaging (MRI),†an Ohio based team began at ECTRIMS 2016.